Immunic Inc. buy tamam
Start price
25.03.20
/
50%
€7.50
Target price
04.11.21
€25.00
Performance (%)
17.93%
End price
05.11.21
€8.85
Summary
This prediction ended on 05.11.21 with a price of €8.85. The BUY prediction by tamam finished with a performance of 17.93%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Immunic Inc. | 0.806% | 0.806% | 26.263% | -23.954% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
Comments by tamam for this prediction
In the thread Immunic Inc. diskutieren
Immunic (NASDAQ:IMUX) announces positive top-line data from its phase 2 EMPhASIS trial of lead asset, IMU-838, the selective oral DHODH inhibitor, in patients with relapsing-remitting multiple sclerosis (RRMS).
In the thread Trading Immunic Inc.
Die von tamam gewählte maximale Laufzeit wurde überschritten